Compugen CGEN
NASDAQ CGEN
$2.35 +0.02 (+0.86%)
At close: Sep 29, 2026 · 4:00 PM EDT

Compugen (CGEN) EV to EBIT (2022 - 2026)

Updated

Compugen's (CGEN) EV to EBIT was 3.85 for Q2 2026, up 12.3% from the prior quarter.

Analysis

Compugen (CGEN) EV to EBIT (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Compugen's EV to EBIT came in at -5.64; for FY2025, it came in at 0.27.

  • The Q2 2026 figure ranks as the highest quarterly EV to EBIT since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Compugen 220.31 Mn -152.78 Mn -92,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.85
Mar 31, 2026 3.43
Dec 31, 2025 0.27
Sep 30, 2024 7.75
Mar 31, 2023 -0.60
Dec 31, 2022 -6.85
Jun 30, 2022 16.74
API Access

Compugen EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=CGEN&period=max&api_key=YOUR_API_KEY